is not part of pass-through pricing formula with customers. Active dialogue is ongoing with customers to re- cover this cost increase. Aforesaid planned turnarounds in 2Q17 that impacted earnings, in
to levels last seen in 2015/16 as reflected in third quarter earnings. This has been achieved despite being negatively impacted by the cost increase from secondary raw material IPA by about $10 per ton
of Baht 335.29377 is reasonable in which the Company will receive the expected return. The share premium will be the asset of Hero Experience for construction cost and investment in future project. 4
of July-December 2017 at Baht of 0.04 per share. The total outstanding shares entitled for the dividend is 4,554,643,575 shares and total dividend amount is Baht 182,185,743, the record date for the
, and (2) the Company recorded the doubtful accounts on long-term loan to joint ventures of 910 million Baht in the same period last year. In Q2 2018, the Company had finance cost of 198 million Baht
the asset of Hero Experience for construction cost and investment in future project. The subscription of the newly issued share of 149.018 Baht per shares is the reasonable amount of which will reflect
of July-December 2017 at Baht of 0.04 per share. The total outstanding shares entitled for the dividend is 4,554,643,575 shares and total dividend amount is Baht 182,185,743, the record date for the
direction primarily by considering the balance of three dimensions – economy, society and environment – under good corporate governance, appropriate risk management and effective cost management. At the same
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
Public Company Limited’s subsidiary company (“The Company”), Joint Venture Ureka UU co., ltd. (“UU”), in which the company hold 90% of the share. The company plans to increase the shareholding to 99%. On